Intuitive Surgical (ISRG) Tops Q2 EPS by 26c
Tweet
Share
E-mail
Get Alerts ISRG Hot Sheet
Price: $411.55 -0.86%
Revenue Growth %: +15.6%
Financial Fact:
Research and development: 62.6M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +15.6%
Financial Fact:
Research and development: 62.6M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Intuitive Surgical (NASDAQ: ISRG) reported Q2 EPS of $2.19, $0.26 better than the analyst estimate of $1.93. Revenue for the quarter came in at $2.44 billion versus the consensus estimate of $2.35 billion.
2025 Financial Outlook
The Company expects the following results for the full year of 2025:
•Worldwide da Vinci procedure growth of approximately 15.5% to 17% in 2025, compared to 17% in 2024.
•Non-GAAP* gross profit margin to be within a range of 66% and 67% of revenue in 2025, compared to 69.1% in 2024. This range includes an estimated impact from tariffs of 1.0% of revenue, plus or minus 20 basis points.
•Non-GAAP* operating expense growth of 10% to 14% in 2025, compared to 10% in 2024
For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Day 7 ALJ Hearing: Prominent Pain Physician Calls State Medical Marijuana System a Ruse
- Citi Adds Four Names to Catalyst Call List
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
